| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Shattuck Labs, Inc. | Director | Stock Option (Right to Buy) | 33,150 | 14 Jul 2025 | Direct | ||
| Instil Bio, Inc. | Director | Stock Option (Right to Buy) | 6,500 | 28 May 2025 | Direct | ||
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.7400 | 01 Jun 2023 | Direct |